Last reviewed · How we verify

Loprox Cream 0.77%

Padagis LLC · Phase 3 active Small molecule

Ciclopirox olamine disrupts fungal cell membrane and mitochondrial function by chelating polyvalent cations, leading to fungal cell death.

Ciclopirox olamine disrupts fungal cell membrane and mitochondrial function by chelating polyvalent cations, leading to fungal cell death. Used for Tinea pedis (athlete's foot), Tinea corporis (ringworm), Tinea cruris (jock itch).

At a glance

Generic nameLoprox Cream 0.77%
Also known asLoprox Cream
SponsorPadagis LLC
Drug classAntifungal agent
TargetFungal cell membrane and mitochondrial enzymes (polyvalent cation-dependent)
ModalitySmall molecule
Therapeutic areaDermatology
PhasePhase 3

Mechanism of action

Ciclopirox is a broad-spectrum antifungal agent that works by inhibiting the transport of essential ions and disrupting multiple fungal metabolic pathways. It chelates iron and other polyvalent cations required for fungal enzyme function, affecting both the cell membrane and mitochondrial respiration. This multi-target mechanism makes it effective against a wide range of dermatophytes, yeasts, and non-dermatophyte molds.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results